BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10686540)

  • 1. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas.
    Porebska I; HarloziƄska A; Bojarowski T
    Tumour Biol; 2000; 21(2):105-15. PubMed ID: 10686540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
    Uner A; Ebinc FA; Akyurek N; Unsal D; Mentes BB; Dursun A
    Exp Oncol; 2005 Sep; 27(3):225-8. PubMed ID: 16244586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
    Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
    Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
    Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis JW; Looijenga LH; Bokemeyer C
    Cancer; 2002 Jul; 95(2):301-8. PubMed ID: 12124830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
    Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
    Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
    Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
    Bansal A; Liu X; McGregor DH; Singh V; Hall S
    Am J Med Sci; 2010 Oct; 340(4):296-300. PubMed ID: 20622650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker.
    Williet N; Petcu CA; Rinaldi L; Cottier M; Del Tedesco E; Clavel L; Dumas O; Jarlot C; Bouarioua N; Roblin X; Peoc'h M; Phelip JM
    Oncotarget; 2017 Mar; 8(10):16507-16517. PubMed ID: 28157706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters.
    Kapitanovic S; Spaventi R; Poljak L; Kapitanovic M; Pavelic ZP; Gluckman JL; Spaventi S; Pavelic K
    Cancer Detect Prev; 1994; 18(2):97-101. PubMed ID: 7912991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical studies on expression of epidermal growth factor receptor (EGFR) and proliferative activity in human colorectal cancers].
    Koike Y
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):166-75. PubMed ID: 8509061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells.
    Contessa JN; Hampton J; Lammering G; Mikkelsen RB; Dent P; Valerie K; Schmidt-Ullrich RK
    Oncogene; 2002 Jun; 21(25):4032-41. PubMed ID: 12037685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas.
    Kim YW; Huh SH; Park YK; Yoon TY; Lee SM; Hong SH
    Oncol Rep; 2001; 8(5):1127-32. PubMed ID: 11496329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
    Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
    Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
    Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
    Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations of c-erb-B2, EGFR, and TGF-alpha expression to recurrence of Dukes'A and B colorectal carcinoma].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW
    Ai Zheng; 2007 Jun; 26(6):647-51. PubMed ID: 17562274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study in acquired cystic disease of the kidney--expression of vimentin, epidermal growth factor, epidermal growth factor receptor and c-erb B2 gene product].
    Horiguchi T; Ishikawa I
    Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):797-807. PubMed ID: 8105122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.